End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 TWD | +3.85% |
|
-22.86% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Li Jen Chen
CEO | Chief Executive Officer | - | 13-12-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zuie Chin Huang
CHM | Chairman | 59 | - |
Li Jen Chen
CEO | Chief Executive Officer | - | 13-12-30 |
Jie Zhang
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 17,557,000 | 0 | 443,000 ( 2.523 %) | - |
Company contact information
TriArm Therapeutics (Taiwan) Ltd.
27F-10 No. 99, Section 1, Xintai 5thn Road
221 01, New Taipei
+
http://www.humorigin.com.tw![address Humorigin Biotechnology Corp(6487)](https://cdn.zonebourse.com/static/address/20708284.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 0 | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- 6487 Stock
- Company Humorigin Biotechnology Corp